Cargando…

HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking

BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shanshan, Nadeau, Peter E, Mergia, Ayalew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501058/
https://www.ncbi.nlm.nih.gov/pubmed/26169283
http://dx.doi.org/10.1186/s12977-015-0188-y
_version_ 1782381000868757504
author Lin, Shanshan
Nadeau, Peter E
Mergia, Ayalew
author_facet Lin, Shanshan
Nadeau, Peter E
Mergia, Ayalew
author_sort Lin, Shanshan
collection PubMed
description BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain the increased risk of atherosclerosis in HIV infected individuals. Since endothelial dysfunction is key in the initial stages of atherosclerosis, we sought to determine whether RCT was affected in human aortic endothelial cells (HAECs). RESULTS: We found that apoA-I does not significantly stimulate cholesterol efflux in HAECs while cholesterol efflux to high-density lipoprotein (HDL) was dramatically reduced in HAECs co-cultured with HIV infected cells. Studies with wild type and Nef defective HIV revealed no significant differences suggesting that multiple factors are working perhaps in concert with Nef to affect cholesterol efflux to HDL from HAECs. Interestingly, treating HAECs with recombinant Nef showed similar effect in HDL mediated cholesterol efflux as observed in HAECs co-cultured with HIV infected cells. Using a detergent-free based subcellular fractionation approach, we demonstrated that exposure of HAECs to HIV infected cells or Nef alone disrupts caveolin 1 (Cav-1) subcellular trafficking upon HDL stimulation. Moreover, Nef significantly enhanced tyrosine 14 phosphorylation of Cav-1 which may have an impact on recycling of Cav-1 and caveolae. CONCLUSION: These results suggest that HIV interferes with cholesterol efflux by HDL in HAECs through the disruption of Cav-1s’ cellular distribution and that multiple factors are involved, possibly including Nef, for the inhibition of HDL mediated cholesterol efflux and alteration of cellular distribution of Cav-1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0188-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4501058
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45010582015-07-15 HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking Lin, Shanshan Nadeau, Peter E Mergia, Ayalew Retrovirology Research BACKGROUND: Human immunodeficiency virus (HIV) infection leads to decreased reverse cholesterol transport (RCT) in macrophages, and Nef mediated down-regulation and redistribution of ATP-binding cassette transporter A1 (ABCA1) are identified as key factors for this effect. This may partially explain the increased risk of atherosclerosis in HIV infected individuals. Since endothelial dysfunction is key in the initial stages of atherosclerosis, we sought to determine whether RCT was affected in human aortic endothelial cells (HAECs). RESULTS: We found that apoA-I does not significantly stimulate cholesterol efflux in HAECs while cholesterol efflux to high-density lipoprotein (HDL) was dramatically reduced in HAECs co-cultured with HIV infected cells. Studies with wild type and Nef defective HIV revealed no significant differences suggesting that multiple factors are working perhaps in concert with Nef to affect cholesterol efflux to HDL from HAECs. Interestingly, treating HAECs with recombinant Nef showed similar effect in HDL mediated cholesterol efflux as observed in HAECs co-cultured with HIV infected cells. Using a detergent-free based subcellular fractionation approach, we demonstrated that exposure of HAECs to HIV infected cells or Nef alone disrupts caveolin 1 (Cav-1) subcellular trafficking upon HDL stimulation. Moreover, Nef significantly enhanced tyrosine 14 phosphorylation of Cav-1 which may have an impact on recycling of Cav-1 and caveolae. CONCLUSION: These results suggest that HIV interferes with cholesterol efflux by HDL in HAECs through the disruption of Cav-1s’ cellular distribution and that multiple factors are involved, possibly including Nef, for the inhibition of HDL mediated cholesterol efflux and alteration of cellular distribution of Cav-1. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12977-015-0188-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-15 /pmc/articles/PMC4501058/ /pubmed/26169283 http://dx.doi.org/10.1186/s12977-015-0188-y Text en © Lin et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Lin, Shanshan
Nadeau, Peter E
Mergia, Ayalew
HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title_full HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title_fullStr HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title_full_unstemmed HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title_short HIV inhibits endothelial reverse cholesterol transport through impacting subcellular Caveolin-1 trafficking
title_sort hiv inhibits endothelial reverse cholesterol transport through impacting subcellular caveolin-1 trafficking
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501058/
https://www.ncbi.nlm.nih.gov/pubmed/26169283
http://dx.doi.org/10.1186/s12977-015-0188-y
work_keys_str_mv AT linshanshan hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking
AT nadeaupetere hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking
AT mergiaayalew hivinhibitsendothelialreversecholesteroltransportthroughimpactingsubcellularcaveolin1trafficking